Navigation Links
HYCOR Broadens Diagnostic Offerings, Announces Agreements to License Biomarkers for Celiac Disease and Rheumatoid Arthritis
Date:7/26/2011

GARDEN GROVE, Calif., July 26, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that it has signed an agreement with Eurospital—a manufacturer of pharmaceutical products, medical-surgical and diagnostic devices—to license its tTG biomarker in all countries covered by the patent (excluding the US and Canada) for its ability to diagnose celiac disease. HYCOR today also announced that it has signed an agreement with AXIS-SHIELD—a developer of in vitro diagnostic tests—to license its anti-CCP biomarker for its ability to diagnose rheumatoid arthritis (RA). Customers will have access to these critical biomarkers from HYCOR in the coming weeks.

"We are pleased to offer HYCOR customers a tool to help clinicians diagnose these devastating, chronic diseases," said Dick Aderman, CEO, HYCOR. "We look forward to continuing to expand our diagnostic offerings, ensuring customers are able to meet the ever-changing needs of the healthcare professionals they serve."

Celiac disease is a condition that damages the lining of the small intestine and prevents it from absorbing nutrients properly, leading to malnutrition. The symptoms of celiac disease vary from one patient to the next, which poses challenges to healthcare professionals in the accurate diagnosis of the disease. If left untreated celiac disease can cause other complications, including autoimmune disease, anemia and hypoglycemia, and, in some instances, certain types of intestinal cancer.(i)

RA is a chronic autoimmune disease that leads to joint inflammation, as well as inflammation of the surrounding tissue. Early diagnosis of the disease, and early aggressive treatment, can delay joint destruction and prevent symptoms from worsening.(ii)

About HYCOR Biomedical, Inc.

Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets the HYTEC™, KOVA® and AUTOSTAT™ brands. The company is focused on delivering products that provide the highest value to clinicians through innovation, reliability and customer service. For more information, please visit www.hycorbiomedical.com.

About Eurospital

Founded in 1948, Eurospital is a scientific organization active in such sectors as diagnostics, pharmaceutical industry and hospital practice. The Company is located in Trieste (ITALY), a city hosting a number of international research centers, which are now gaining increasing scientific importance in the field of biotechnology. The company is focused on the diagnosis of celiac diseases, gastroenterology, infectious diseases, septic infections.

About AXIS-SHIELD

Axis-Shield (www.axis-shield.com) is an international and innovative in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group specializes in the supply of instruments and tests for the rapidly growing physician's office testing market and the development, manufacture and marketing of innovative proprietary diagnostics kits in areas of clinical need, including cardiovascular and neurological diseases, rheumatoid arthritis, and diabetes.

(i) PubMed Health, available at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001280/, accessed July 15, 2011

(ii) PubMed Health, available at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001467/, accessed July 15, 2011


'/>"/>
SOURCE HYCOR Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HYCOR Appoints Sean-Xavier Neath as Chief Medical Officer to Support Expansion of Product Lines and Enhance Customer Support Offerings
2. HYCOR Expands Board of Directors to Support Growth in Key Areas
3. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
4. United Spinal Association Broadens Its Reach with Users First: Giving Voice to All Wheelchair Users
5. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
6. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
7. FDA Broadens Clearance for Agendias MammaPrint(R)
8. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
9. BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
10. Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
11. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... -- UCB is pleased to announce that 12 scientific abstracts have ... American Epilepsy Society (AES) Annual Meeting, which takes place ... USA. 1-12 Data being presented include ... ® (lacosamide) CV and BRIVIACT ® (brivaracetam) CV. ... state of the union of epilepsy care and antiepileptic drugs ...
(Date:12/2/2016)... -- Allergan plc (NYSE: AGN ), a leading ... announced Accelerated Share Repurchase (ASR) Program. Logo - ... , ... announced, the Company entered into a variable tenor ASR arrangement ... $10 billion of its ordinary shares. Approximately 40.5 million shares ...
(Date:11/30/2016)... , Nov 30, 2016 Research and ... Intracranial Pressure Monitoring Devices 2017 - MedCore" report to their offering. ... , , ... brain and the skull. In healthy individuals, it is circulated though the ... are cases where the amount of CSF surrounding the brain changes significantly. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 2016 , ... Center for Autism and Related Disorders (CARD) Portland today announced ... disorder (ASD) and other developmental disabilities. The group, which is being launched with the ... the opportunity to share stories and advice, seek help, and continue their education on ...
(Date:12/2/2016)... ... 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the cover of ... was inspired to practice medicine at an early age by his father, who was ... diagnoses and prescribing medicine,” he states. “It is about building relationships with people; relationships ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens report losing ... report speaking with their child about sex related topics, less than 60 percent spoke ... proud to announce the launch of its second edition of the “Sexual Wellness” campaign, ...
(Date:12/2/2016)... ... 02, 2016 , ... CloudLIMS.com, a class-leading provider of Laboratory ... CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of their ... version is a faster and a more efficient product, allowing batch processing of ...
Breaking Medicine News(10 mins):